IP Verse

Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs

Patent No. EP3766518 (titled "Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs") was filed by Boehringer Ingelheim on Dec 28, 2006. The application was issued on Jan 28, 2026.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LABORATORIOS HIPRAJan 28, 2026GRUNECKER PATENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3766518

BOEHRINGER INGELHEIM
Application Number
EP20184598A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Dec 26, 2025
Publication Date
Jan 28, 2026
External Links
Slate, Register , Google Patents